Long-term captopril treatment improves diastolic filling more than systolic performance in rats with large myocardial infarction

Cardiovascular Division, Salt Lake City Veterans Affairs Medical Center, Utah 84148, USA.

OBJECTIVES: This study sought to determine the effects of long-term angiotensin-converting enzyme (ACE) inhibition on left ventricular (LV) diastolic filling in postinfarction heart failure. BACKGROUND: Long-term treatment with ACE inhibitors is beneficial in experimental animals and patients with heart failure. Because this treatment typically produces only small improvements in LV systolic function, we hypothesized that improvements in LV diastolic filling might contribute to the overall beneficial effects of ACE inhibitors after myocardial infarction (MI). METHODS: We performed transthoracic echocardiographic-Doppler examinations in rats 1 and 6 weeks after transmural MI or sham operation. Rats with MI were randomized to no treatment (n = 10) or captopril (2 g/liter in drinking water, n = 8) after the baseline echocardiogram. RESULTS: Six weeks after MI, untreated rats had significant LV dilation compared with sham-operated rats (LV diastolic dimension [mean+/-SEM] 10.7 +/- 0.3 vs. 8.5 +/- 0.3 mm, p < 0.05). Rats with untreated MI also had impaired fractional shortening (9 +/- 1% vs. 34 +/- 2%, p < 0.05) and depressed systolic thickening of the noninfarcted posterior wall (3% +/- 3% vs, 65 +/- 9%, p < 0.05). Rats with MI showed progressively restricted LV diastolic filling as assessed by transmitral Doppler recordings. At 6 weeks, peak early filling velocity (E) was increased (97 +/- 3 vs. 77 +/- 2 cm/s, p < 0.05), E wave deceleration was more rapid (23 +/- 3 vs. 12 +/- 1 m/s2, p < 0.05), isovolumetric relaxation time was decreased (18 +/- 1 vs. 24 +/- 1 ms, p < 0.05), and late filling velocity was lower (26 +/- 7 vs. 34 +/- 1 cm/s, p < 0.05) in rats with MI versus sham-operated rats. Compared with rats with untreated MI, rats receiving captopril had similar LV diastolic dimensions (10.5 +/- 0.35 vs. 10.7 +/- 0.35 mm), slightly higher fractional shortening (16 +/- 2% vs. 9 +/- 1%, p < 0.05 [captopril MI vs. untreated MI]) and unchanged posterior wall thickening (49 +/- 12% vs. 37 +/- 3%, p = 0.3). In contrast, captopril almost completely normalized diastolic filling abnormalities (E velocity 82 +/- 5 cm/s, p < 0.05 [captopril MI vs. untreated MI]; E wave deceleration rate 15 +/- 2 m/s2, p < 0.05 [captopril MI vs. untreated MI]; isovolumetric relaxation time 20 +/- 1 ms). CONCLUSIONS: Long-term captopril treatment in rats with a large MI modestly limits LV remodeling and the development of systolic dysfunction but markedly improves the restrictive diastolic filling abnormalities that are seen in untreated rats.

This article has been cited by other articles:

				Y.-F. Chen, R. A. Redetzke, S. Said, A. J. Beyer, and A. M. Gerdes Changes in left ventricular function and remodeling after myocardial infarction in hypothyroid rats Am J Physiol Heart Circ Physiol, January 1, 2010; 298(1): H259 - H262. [Abstract] [Full Text] [PDF]

				E. L. Olivares, R. H. Costa-e-Sousa, J. P.S. Werneck-de-Castro, V. Pinho-Ribeiro, M. G. Silva, K. C. Ribeiro, E. C. Mattos, R. C.S. Goldenberg, A. C. C. de Carvalho, and M. O. Masuda Cellular cardiomyoplasty in large myocardial infarction: Can the beneficial effect be enhanced by ACE-inhibitor therapy? Eur J Heart Fail, June 1, 2007; 9(6-7): 558 - 567. [Abstract] [Full Text] [PDF]

				X. Hu, J. Wang, J. Chen, R. Luo, A. He, X. Xie, and J. Li Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction Eur J Cardiothorac Surg, March 1, 2007; 31(3): 438 - 443. [Abstract] [Full Text] [PDF]

				Y.-L. Sun, S.-J. Hu, L.-H. Wang, Y. Hu, and J.-Y. Zhou Effect of {beta}-Blockers on Cardiac Function and Calcium Handling Protein in Postinfarction Heart Failure Rats Chest, September 1, 2005; 128(3): 1812 - 1821. [Abstract] [Full Text] [PDF]

				A. Cittadini, M. G. Monti, J. Isgaard, C. Casaburi, H. Stromer, A. Di Gianni, R. Serpico, L. Saldamarco, M. Vanasia, and L. Sacca Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure Cardiovasc Res, June 1, 2003; 58(3): 555 - 564. [Abstract] [Full Text] [PDF]

				T. Sugie, Y. Kagaya, M. Takeda, H. Yahagi, C. Takahashi, J. Takahashi, M. Ninomiya, J. Watanabe, R. Ichinohasama, F. Tezuka, et al. Should increasing the dose or adding an AT1 receptor blocker follow a relatively low dose of ACE inhibitor initiated in acute myocardial infarction? Cardiovasc Res, June 1, 2003; 58(3): 611 - 620. [Abstract] [Full Text] [PDF]

				T. Nomoto, T. Nishina, S. Miwa, H. Tsuneyoshi, I. Maruyama, K. Nishimura, and M. Komeda Angiotensin-Converting Enzyme Inhibitor Helps Prevent Late Remodeling After Left Ventricular Aneurysm Repair in Rats Circulation, September 24, 2002; 106(12_suppl_1): I-115 - I-119. [Abstract] [Full Text] [PDF]

				Yuejin Yang, Yida Tang, Yingmao Ruan, Yongli Li, Yanwen Zhou, Runlin Gao, Jilin Chen, and Zaijia Chen Comparative effects of cilazapril, carvedilol and their combination in preventing from left ventricular remodelling after acute myocardial infarction in rats Journal of Renin-Angiotensin-Aldosterone System, March 1, 2002; 3(1): 31 - 35. [Abstract] [PDF]

				J.-Y. Min, Y. Yang, K. L. Converso, L. Liu, Q. Huang, J. P. Morgan, and Y.-F. Xiao Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats J Appl Physiol, January 1, 2002; 92(1): 288 - 296. [Abstract] [Full Text] [PDF]

				M. Yoshiyama, K. Takeuchi, T. Omura, S. Kim, H. Yamagishi, I. Toda, M. Teragaki, K. Akioka, H. Iwao, and J. Yoshikawa Effects of Candesartan and Cilazapril on Rats With Myocardial Infarction Assessed by Echocardiography Hypertension, April 1, 1999; 33(4): 961 - 968. [Abstract] [Full Text] [PDF]